• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症肝脏中的酶诱导作用。

Enzyme induction in the uremic liver.

作者信息

Leber H W, Gleumes L, Schütterle G

出版信息

Kidney Int Suppl. 1978 Jun(8):S43-8.

PMID:99598
Abstract

Forty-five days after subtotal nephrectomy or sham-operation of male rats, microsomal enzymes were investigated in vitro. The activities (per milligram) of microsomal protein of two esterases and of two glucuronyltransferases were normal in the uremic rats. The mixed-function oxidation system had lower activities per milligram of protein than that in sham-operated controls. Due to a decrease of the microsomal protein content of the uremic liver, the activities of these enzymes were decreased when calculated for the whole liver. In contrast, the glucoronidation of phenolphthalein remained normal when related to the whole liver, due to an increased activity per mg of protein. Treatment with the plasticizer di-(2-ethylhexyl)-phthalate caused a significant increase of the liver wet weight, the microsomal protein content, and the activity per mg of protein for the demethylation of aminopyrine in subtotally nephrectomized rats but was without influence on the liver of sham-operated controls. It is concluded that uremia itself does not induce liver microsomal enzymes. The microsomal enzymes, however, remain inducible by foreign compounds even under uremic conditions.

摘要

雄性大鼠进行肾次全切除或假手术后45天,对微粒体酶进行体外研究。在尿毒症大鼠中,两种酯酶和两种葡萄糖醛酸转移酶的微粒体蛋白活性(每毫克)正常。混合功能氧化系统每毫克蛋白的活性低于假手术对照组。由于尿毒症肝脏微粒体蛋白含量降低,按全肝计算时这些酶的活性降低。相比之下,酚酞的葡萄糖醛酸化与全肝相关时仍保持正常,因为每毫克蛋白的活性增加。用增塑剂邻苯二甲酸二(2-乙基己基)酯处理导致肾次全切除大鼠的肝脏湿重、微粒体蛋白含量以及氨基比林去甲基化每毫克蛋白的活性显著增加,但对假手术对照组的肝脏无影响。结论是尿毒症本身不会诱导肝脏微粒体酶。然而,即使在尿毒症条件下,微粒体酶仍可被外来化合物诱导。

相似文献

1
Enzyme induction in the uremic liver.尿毒症肝脏中的酶诱导作用。
Kidney Int Suppl. 1978 Jun(8):S43-8.
2
Influence of the plasticiser di-2-ethylhexyl-phthalate on drug metabolising enzymes in the liver of uraemic rats.增塑剂邻苯二甲酸二(2-乙基己基)酯对尿毒症大鼠肝脏药物代谢酶的影响。
Proc Eur Dial Transplant Assoc. 1979;16:232-7.
3
Effect of uremia on rates of ethanol disappearance from the blood and on the activities of the ethanol-oxidizing enzymes.尿毒症对乙醇从血液中消失的速率以及乙醇氧化酶活性的影响。
J Lab Clin Med. 1975 Dec;86(6):931-7.
4
A comparison of the inductive effects of phenobarbital, methaqualone, and methyprylon on hepatic mixed function oxidase enzymes in the rat.
Res Commun Chem Pathol Pharmacol. 1975 May;11(1):45-53.
5
Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.膳食硫胺素对苯巴比妥诱导大鼠肝脏中负责代谢药物和致癌物的酶的影响。
Drug Nutr Interact. 1983;2(2):117-30.
6
Microsomal mixed-function oxidase and activities of some related enzymes in hyperplastic nodules induced by long-term griseofulvin administration in mouse liver.
Cancer Res. 1980 Jul;40(7):2568-73.
7
Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
Int J Clin Pharmacol Res. 1983;3(6):431-6.
8
Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.水飞蓟宾对大鼠肝脏微粒体药物代谢酶系统的影响。
Arzneimittelforschung. 1974 Dec;24(12):1986-8.
9
Effect of hepatic microsomal mixed-function oxidase activities in rats pretreated with Nocardia rubra cell wall skeleton.红色诺卡氏菌细胞壁骨架预处理大鼠对肝微粒体混合功能氧化酶活性的影响。
Res Commun Chem Pathol Pharmacol. 1982 Aug;37(2):267-77.
10
Postnatal development of mixed-function oxidation and conjugation in hemoglobin-free perfused rat liver.无血红蛋白灌注大鼠肝脏中混合功能氧化和结合作用的产后发育
J Pharmacol Exp Ther. 1981 Mar;216(3):473-8.

引用本文的文献

1
Alterations of Hepatic Metabolism in Chronic Kidney Disease via D-box-binding Protein Aggravate the Renal Dysfunction.慢性肾脏病中通过D盒结合蛋白引起的肝脏代谢改变加重肾功能障碍。
J Biol Chem. 2016 Mar 4;291(10):4913-27. doi: 10.1074/jbc.M115.696930. Epub 2016 Jan 4.
2
Reduced hepatic synthesis of calcidiol in uremia.尿毒症时钙二醇的肝脏合成减少。
J Am Soc Nephrol. 2010 Sep;21(9):1488-97. doi: 10.1681/ASN.2009080815. Epub 2010 Jul 1.
3
The effect of chronic renal failure on drug metabolism and transport.慢性肾衰竭对药物代谢和转运的影响。
Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1065-74. doi: 10.1517/17425255.4.8.1065.
4
Downregulation of hepatic acetylation of drugs in chronic renal failure.慢性肾衰竭时肝脏药物乙酰化作用下调。
J Am Soc Nephrol. 2008 Jul;19(7):1352-9. doi: 10.1681/ASN.2007090974. Epub 2008 Apr 16.
5
Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450.慢性肾衰竭患者血清对大鼠肝脏细胞色素P450的影响。
Br J Pharmacol. 2005 Apr;144(8):1067-77. doi: 10.1038/sj.bjp.0706138.
6
Quinine pharmacokinetics in chronic haemodialysis patients.慢性血液透析患者的奎宁药代动力学
Br J Clin Pharmacol. 2002 Dec;54(6):604-9. doi: 10.1046/j.1365-2125.2002.01680.x.
7
Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.慢性肾衰竭时肝脏细胞色素P450的下调:尿毒症介质的作用
Br J Pharmacol. 2002 Dec;137(7):1039-46. doi: 10.1038/sj.bjp.0704951.
8
The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction.安乃近及其代谢产物在急性肾功能不全重症监护患者中的动力学。
Eur J Clin Pharmacol. 1993;45(5):445-50. doi: 10.1007/BF00315516.
9
Pharmacokinetics of tenoxicam in patients with impaired renal function.
Eur J Clin Pharmacol. 1986;29(6):697-701. doi: 10.1007/BF00615961.
10
Assessment of liver ability to biotransformation of antipyrine in uraemic patients on regular peritoneal dialysis treatment.
Int Urol Nephrol. 1989;21(5):541-5. doi: 10.1007/BF02549593.